The Ratio of CD8 to Treg Tumor-Infiltrating Lymphocytes Is Associated With Response to Cisplatin-Based Neoadjuvant Chemotherapy in Patients With Muscle Invasive Urothelial Carcinoma of the Bladder

OncoImmunology - United States
doi 10.1080/2162402x.2015.1134412
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Amplification of 7p12 Is Associated With Pathologic Non-Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2020English

Gemcitabine and Cisplatin Neoadjuvant Chemotherapy for Muscle-Invasive Urothelial Carcinoma: Predicting Response and Assessing Outcomes

Urologic Oncology: Seminars and Original Investigations
OncologyUrology
2015English

Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder

Japanese Journal of Urology
Urology
2015English

The Quest for an Ideal Neoadjuvant Systemic Therapy in Cisplatin‐Ineligible Patients With Muscle‐Invasive Localized Urothelial Carcinoma

Oncologist
Cancer ResearchMedicineOncology
2019English

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin‐Based Chemotherapy for Muscle‐Invasive Bladder Cancer

Oncologist
Cancer ResearchMedicineOncology
2019English

Retrospective Analysis of Clinical Outcomes With Neoadjuvant Cisplatin-Based Regimens for Muscle-Invasive Bladder Cancer

Clinical Genitourinary Cancer
OncologyUrology
2012English

Is BCL-2 a Predictive Marker of Neoadjuvant Chemotherapy Response in Patients With Urothelial Bladder Cancer Undergoing Radical Cystectomy?

Scandinavian Journal of Urology
UrologyNephrology
2019English

Neoadjuvant Chemotherapy Prior to Radical Cystectomy for Muscle-Invasive Bladder Cancer With Variant Histology

Cancer
Cancer ResearchOncology
2017English

The Role of Neutrophil to Lymphocyte Ratio in Patients With pTa Non-Muscle Invasive Bladder Cancer

Revista Romana de Medicina de Laborator
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy